Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice

Br J Nutr. 2021 May 28;125(10):1081-1091. doi: 10.1017/S0007114520003013. Epub 2020 Jul 28.

Abstract

Probiotics and plant extracts are considered to prevent the development of non-alcoholic fatty liver disease (NAFLD). The present study explores the effects of using both probiotics and plant extracts on NAFLD. The present study evaluated the effects of plant extracts on lipid droplet accumulation and the growth of probiotics in vitro. A C57BL/6 mouse model was used to examine the effects of probiotics and plant extracts on NAFLD. Body weight and food intake were measured. The levels of serum lipids, oxidative stress and the liver injury index were determined using commercial kits. Haematoxylin and eosin staining, GC and real-time PCR were also used for analysis. The results revealed that administration of Lactobacillus casei YRL577 and L. paracasei X11 with resveratrol (RES) or tea polyphenols (TP) significantly reduced the levels of total cholesterol, TAG and LDL-cholesterol and increased the level of the HDL-cholesterol. The groups of L. casei YRL577 with RES and TP also regulated the liver structure, oxidative stress and injury. Furthermore, L. casei YRL577 with TP exhibited a more positive effect towards improving the NAFLD and increased the concentrations of the butyric acid than other three combined groups. L. casei YRL577 with TP up-regulated the mRNA levels of the farnesoid X receptor and fibroblast growth factor 15 and decreased the mRNA levels of the apical Na-dependent bile acid transporter. These findings showed that L. casei YRL577 + TP-modified genes in the intestinal bile acid pathway improved markers of NAFLD.

Keywords: Intestinal bile acid pathway; Lipid accumulation; Non-alcoholic fatty liver; Plant extracts; Probiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism
  • Body Weight
  • Camellia sinensis / chemistry
  • Diet, High-Fat / adverse effects
  • Gene Expression Regulation / drug effects
  • Glycine max / chemistry
  • Hep G2 Cells
  • Humans
  • Isoflavones / chemistry
  • Isoflavones / therapeutic use*
  • Lacticaseibacillus casei*
  • Lipid Metabolism / drug effects
  • Liver / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / chemically induced
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Organ Size / drug effects
  • Polyphenols / administration & dosage
  • Polyphenols / chemistry
  • Polyphenols / therapeutic use*
  • Probiotics / therapeutic use*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Resveratrol / chemistry
  • Resveratrol / therapeutic use*

Substances

  • Bile Acids and Salts
  • Isoflavones
  • Polyphenols
  • Receptors, Cytoplasmic and Nuclear
  • farnesoid X-activated receptor
  • Resveratrol